<DOC>
	<DOCNO>NCT02203721</DOCNO>
	<brief_summary>The purpose clinical trial evaluate safety effectiveness TECNIS Symfony Extended Range Vision IOL .</brief_summary>
	<brief_title>Clinical Investigation New Intraocular Lens</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Minimum 22 year age Bilateral cataracts phacoemulsification extraction posterior IOL implantation plan eye Preoperative best correct distance visual acuity ( BCDVA ) 20/40 Snellen bad without glare source Potential postoperative BCDVA 20/30 Snellen good Corneal astigmatism Clear intraocular medium , cataract Availability , willingness sufficient cognitive awareness comply examination procedure Signed informed consent HIPAA authorization Ability understand respond questionnaire English Spanish Requiring intraocular lens power outside available range +16.0 D +28.0 D Pupil abnormalities Recent ocular trauma ocular surgery resolved/stable may affect visual outcome increase risk subject Prior corneal refractive intraocular surgery Corneal abnormalities Inability achieve keratometric stability contact lens wearer Subjects diagnose degenerative visual disorder predict cause visual acuity loss level 20/30 Snellen bad study Subjects condition associate increase risk zonular rupture , include capsular zonular abnormality may lead IOL decentration tilt , pseudoexfoliation , trauma , posterior capsule defect Use systemic ocular medication may affect vision Prior , current , anticipated use course 6month study tamsulosin silodosin , may , opinion investigator , confound outcome increase risk subject Inability focus fixate prolong period time Poorlycontrolled diabetes Acute , chronic , uncontrolled systemic ocular disease illness , opinion investigator , would increase operative risk confound outcome ( ) study . May expect require retinal laser treatment surgical intervention course study Patient pregnant , plan become pregnant , lactate another condition associate fluctuation hormone could lead refractive change Concurrent participation participation within 30 day prior preoperative visit clinical trial Desire monovision correction</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>